PEDIATRICS Vol. 95 No. 6 June 1995, pp. 888-891
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Donowitz, L. G.
Right arrow Articles by Hendley, J. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Donowitz, L. G.
Right arrow Articles by Hendley, J. O.

Short-Course Amphotericin B Therapy for Candidemia in Pediatric Patients

Leigh G. Donowitz MD1 and J. Owen Hendley MD1

1 Department of Pediatrics, University of Virginia Health Sciences Center, Charlottesville

Objective. To determine the efficacy of short-course (7 to 14 days of therapy after the last positive blood culture) amphotericin B therapy for candidemia in children.

Design. Case series.

Setting. Tertiary care university medical center in Virginia.

Patients. Thirty patients younger than 17 years of age who had candidemia between 1983 and 1990.

Measurements and results. The charts of 30 children with 31 episodes of candidemia were retrospectively reviewed for patient data, dates of positive and negative cultures for Candida from blood and other sites, dates of removal of the intravascular catheters, duration and dosage of amphotericin B administration, and outcome. Eight patients had persistent candidemia and died. Five patients were treated not in accordance with the short-course recommendations. Two had relapses; 1 was cured with catheter removal alone, and 2 were successfully treated with 26 and 30 days of amphotericin B therapy. Eighteen episodes (two episodes in 1 patient) of candidemia were cured using 7 to 14 days of amphotericin B therapy after the last positive blood culture.

Conclusions. Once the bloodstream is sterilized, and there is no other evidence of invasive fungal disease, 7 to 14 additional days of amphotericin B at a dose of 0.5 mg/kg per day seems adequate for treatment of candidemia in children.

Submitted on April 25, 1994
Accepted on September 16, 1994




This article has been cited by other articles:


Home page
 PediatricsHome page
C. C. Blyth, P. Palasanthiran, and T. A. O'Brien
Antifungal Therapy in Children With Invasive Fungal Infections: A Systematic Review
Pediatrics, April 1, 2007; 119(4): 772 - 784.
[Abstract] [Full Text] [PDF]

Home page
 NeoReviewsHome page
S. D. Kicklighter
Antifungal Agents and Fungal Prophylaxis in the Neonate
NeoReviews, December 1, 2002; 3(12): e249 - 255.
[Full Text] [PDF]

Home page
 JWatch GeneralHome page
SHORTER THERAPY IN CHILDREN WITH CANDIDEMIA
Journal Watch (General), June 20, 1995; 1995(620): 4 - 4.
[Full Text]